NCT00405730|CompletedPhase 3
Loading search results
Sponsor study identifier
Secondary identifiers
NIH
interventional
227
1 country
1
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2006
Actual (reported)Study Completion
July 2006
Actual (reported)To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment of ocular inflammation and ocular pain after cataract extraction with IOL implantation
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2006
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
July 2006
Actual (reported)July 2006
Actual (reported)November 29, 2006
Actual (reported)November 30, 2006
Actual (reported)Percentage of Patients with Day 14 Cure
Cure is defined as aqueous cells score = 0 and aqueous cells score = 0 at Day 14.
Day 14
One drop in the study eye 3 times daily for 23 days
One drop in the study eye 3 times daily for 23 days
One drop in the study eye 3 times daily for 23 days
One drop in the study eye 3 times daily for 23 days
One drop in the study eye 3 times daily for 23 days
Bordeaux
Bordeaux, 33000, France
Nardi M, Lobo C, Bereczki A, Cano J, Zagato E, Potts S, Sullins G, Notivol R. Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery. Clin Ophthalmol. 2007 Dec;1(4):527-33.
227 participants (actual enrollment reported by the registry).
First Submitted
November 29, 2006
First Posted
November 30, 2006
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
A Bioequivalence Study of Tobradex AF
One drop in the study eye 3 times daily for 23 days
Contact the study team to confirm eligibility.
Primary Completion
July 2006
Actual (reported)Study Completion
July 2006
Actual (reported)Last Updated
November 18, 2016
Record last verified: 2012-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: